Artigo Acesso aberto Revisado por pares

Outcome of orthotopic liver transplantation in autoimmune hepatitis according to subtypes

2002; Springer Science+Business Media; Volume: 15; Issue: 1 Linguagem: Inglês

10.1111/j.1432-2277.2002.tb00095.x

ISSN

1432-2277

Autores

Pierre Cattan, Thierry Berney, Filoména Conti, Yvon Calmus, J C Homberg, D Houssin, Olivier Soubrane,

Tópico(s)

Liver Disease Diagnosis and Treatment

Resumo

Transplant InternationalVolume 15, Issue 1 p. 34-38 Free to Read Outcome of orthotopic liver transplantation in autoimmune hepatitis according to subtypes Pierre Cattan, Corresponding Author Pierre Cattan Service de Chirurgie Digestive, Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, 75475 Paris Cedex 10, France Service de Chirurgie, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75679 Paris Cedex 14, FranceTel.: +33-1-42499713 Fax: +33-1-42499757Search for more papers by this authorThierry Berney, Thierry Berney Visceral and Transplant Surgery, Geneva University Hospital, 24 rue Micheli du Crest, 1205 Geneva, CP 1211, SwitzerlandSearch for more papers by this authorFilomena Conti, Filomena Conti Service de Chirurgie, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75679 Paris Cedex 14, FranceSearch for more papers by this authorYvon Calmus, Yvon Calmus Service de Chirurgie, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75679 Paris Cedex 14, FranceSearch for more papers by this authorJ.C. Homberg, J.C. Homberg Laboratoire Central d'Immunologie et d'Hématologie, Hôpital Saint-Antoine, 184 rue du Faubourg Saint-Antoine, 75012 Paris, FranceSearch for more papers by this authorDidier Houssin, Didier Houssin Service de Chirurgie, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75679 Paris Cedex 14, FranceSearch for more papers by this authorOlivier Soubrane, Olivier Soubrane Service de Chirurgie, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75679 Paris Cedex 14, FranceSearch for more papers by this author Pierre Cattan, Corresponding Author Pierre Cattan Service de Chirurgie Digestive, Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, 75475 Paris Cedex 10, France Service de Chirurgie, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75679 Paris Cedex 14, FranceTel.: +33-1-42499713 Fax: +33-1-42499757Search for more papers by this authorThierry Berney, Thierry Berney Visceral and Transplant Surgery, Geneva University Hospital, 24 rue Micheli du Crest, 1205 Geneva, CP 1211, SwitzerlandSearch for more papers by this authorFilomena Conti, Filomena Conti Service de Chirurgie, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75679 Paris Cedex 14, FranceSearch for more papers by this authorYvon Calmus, Yvon Calmus Service de Chirurgie, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75679 Paris Cedex 14, FranceSearch for more papers by this authorJ.C. Homberg, J.C. Homberg Laboratoire Central d'Immunologie et d'Hématologie, Hôpital Saint-Antoine, 184 rue du Faubourg Saint-Antoine, 75012 Paris, FranceSearch for more papers by this authorDidier Houssin, Didier Houssin Service de Chirurgie, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75679 Paris Cedex 14, FranceSearch for more papers by this authorOlivier Soubrane, Olivier Soubrane Service de Chirurgie, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75679 Paris Cedex 14, FranceSearch for more papers by this author First published: 11 March 2005 https://doi.org/10.1111/j.1432-2277.2002.tb00095.xCitations: 20AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Abstract Abstract The relevance of autoimmune hepatitis (AIH) classification for clinical purposes is controversial. We analyzed the outcome after orthotopic liver transplantation (OLT) of nine type I and seven type II AIH patients. Type II patients had a significantly higher incidence of cirrhosis at the time of diagnosis, more resistance to steroid therapy, and a higher Child-Pugh score at the time of OLT. OLT was performed in emergency in three type II patients and electively in all type I patients. Four type II and one type I patients died in the postoperative period. There was no difference regarding the incidence of post-OLT infection and rejection between the two types. The 6-year actuarial survival rates for type I and type II patients were 76% and 43%, respectively. Type II AIH patients who have a poor response to medical therapy should be considered for OLT with a shortened delay. References 1 Czaja A, Carpenter HA (1996) Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci 41: 305–314. 10.1007/BF02093820 CASPubMedWeb of Science®Google Scholar 2 Czaja AJ, Manns MP (1995) The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol 90: 1206–1211. CASPubMedWeb of Science®Google Scholar 3 Czaja AJ, Rakela J, Ludwig J (1988) Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis. Gastroenterology 95: 448–453. 10.1016/0016-5085(88)90503-3 CASPubMedWeb of Science®Google Scholar 4 Davis GL, Czaja AJ, Ludwig J (1984) Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis. Gastroenterology 87: 1222–1227. 10.1016/0016-5085(84)90186-0 CASPubMedWeb of Science®Google Scholar 5 Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ (1994) Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513–1520. 10.1002/hep.1840190629 CASPubMedWeb of Science®Google Scholar 6 Donaldson PT, Doherty DG, Hayllar KM, MacFarlance IG, Johnson PJ, Williams R (1990) Susceptibility to auto-immune chronic active hepatitis: HLA DR4 and A1B8DR3 are independent risk factors. Hepatology 13: 701–706. 10.1002/hep.1840130415 Web of Science®Google Scholar 7 Garner JS, Jarvis WR Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections. Am J Infect Control 66: 128–140. 10.1016/0196-6553(88)90053-3 Web of Science®Google Scholar 8 Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, Darnis F, Lévy VG, Grippon P, Opollon P, Bernuau J, Benhamou JP, Alagille D (1987) Chronic active hepatitis associated with anti-liver/kidney microsome antibody type I: a second type of "autoimmune" hepatitis. Hepatology 7: 1333–1339. 10.1002/hep.1840070626 CASPubMedWeb of Science®Google Scholar 9 Houssin D, Soubrane O, Boillot O, Dousset B, Ozier Y, Devictor D, Berbard O, Chapuis Y (1992) Orthotopic liver transplantation with a reduced-size graft: an ideal compromise in pediatrics Surgery 111: 532–542. PubMedWeb of Science®Google Scholar 10 Houssin D, Boillot O, Soubrane O, Couinaud C, Pitre J, Ozier Y, Devictor D, Bernard O, Chapuis Y (1993) Controlled liver splitting for transplantation in two recipients: technique, results and perspectives. Br J Surg 80: 75–80. 10.1002/bjs.1800800126 PubMedWeb of Science®Google Scholar 11 International Working Party (1995) Terminology of chronic hepatitis. Am J Gastroenterol 90: 181–189. PubMedGoogle Scholar 12 Johnson PJ, McFarlane IG (1993) Meeting report. International Autoimmune Hepatitis Group. Hepatology 18: 998–1005. 10.1002/hep.1840180435 CASPubMedWeb of Science®Google Scholar 13 Johnson PJ, McFarlane IG, Eddelson ALWF (1991) The natural course and heterogeneity of autoimmune type chronic active hepatitis. Semin Liver Dis 11: 187–196. 10.1055/s-2008-1040436 PubMedWeb of Science®Google Scholar 14 Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Buschenfelde KH (1987) Characterization of a new subgroup of autoimmune chronic hepatitis by autoantibodies against a soluble liver antigen. Lancet I: 292–294. 10.1016/S0140-6736(87)92024-1 Google Scholar 15 Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, Resta S, Dunn D, Gamberg P, Ratkovec RM (1992) A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med 326: 1182–1186. 10.1056/NEJM199204303261803 CASPubMedWeb of Science®Google Scholar 16 Milkiewicz P, Ahmed M, Hathaway M, Elias E (1999) Factors associated with progression of the disease before transplantation in patients with autoimmune hepatitis. Liver 19: 50–54. 10.1111/j.1478-3231.1999.tb00009.x CASPubMedWeb of Science®Google Scholar 17 Murray-Lyon IM, Stern RB, Williams R (1973) Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet I: 735–737. 10.1016/S0140-6736(73)92125-9 Google Scholar 18 Nikias GA, Batts KP, Czaja AJ (1994) The nature and prognostic implications of "acute" type I autoimmune hepatitis. Gastroenterology 106: A950. Web of Science®Google Scholar 19 Porta G, Da Costa Gayotto LC, Alvarez F (1990) Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure. J Pediatr Gastroenterol Nutr 11: 138–140. 10.1002/j.1536-4801.1990.tb10074.x CASPubMedWeb of Science®Google Scholar 20 Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 646–649. 10.1002/bjs.1800600817 CASPubMedWeb of Science®Google Scholar 21 Ratziu V, Samuel D, Sebagh M, Farges O, Saliba F, Icai P, Farahmand H, Gigou M, Feray C, Reynes M, Bismuth H (1999) Longterm follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. J Hepatol 30: 131–141. 10.1016/S0168-8278(99)80017-8 CASPubMedWeb of Science®Google Scholar 22 Roberts SK, Therneau TM, Czaja AJ (1996) Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 110: 848–857. 10.1053/gast.1996.v110.pm8608895 CASPubMedWeb of Science®Google Scholar 23 Roitt IM, Doniach D (1972) Immunofluorescent tests for the detection of antibodies. In: WHO booklet of immunological techniques. WHO, Geneva . pp 1–12. Google Scholar 24 Sanchez-Urdazpal L, Czaja AJ, van Hoek B, Krom RA, Wiesner RH (1992) Prognosis features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology 15: 215–221. 10.1002/hep.1840150208 CASPubMedWeb of Science®Google Scholar 25 Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL (1987) Liver rejection: an analysis of the use of biopsy in determining outcome of rejection. Am J Surg 11: 1–10. 10.1097/00000478-198701000-00001 PubMedWeb of Science®Google Scholar 26 Starzl TE, Iwatsuki S, Esquivel CO, Todo S, Kam I, Lynch S, Gordon RD, Shaw BW Jr (1985) Refinements in the surgical technique of liver transplantation. Semin Liver Dis 5: 349–356. 10.1055/s-2008-1040632 PubMedWeb of Science®Google Scholar 27 Wright HL, Bou-Abboud CF, Hassanein T, Block GD, Demetris AJ, Starzl TE, Van Thiel DH (1992) Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease. Transplantation 53: 136–139. 10.1097/00007890-199201000-00027 CASPubMedWeb of Science®Google Scholar Citing Literature Volume15, Issue1January 2002Pages 34-38 ReferencesRelatedInformation

Referência(s)
Altmetric
PlumX